MiCo BioMed Co., Ltd.

KOSDAQ:A214610 Stock Report

Market Cap: ₩62.8b

MiCo BioMed Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Young S Hong

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownership0.03%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Is MiCo BioMed (KOSDAQ:214610) Using Debt In A Risky Way?

Apr 12
Is MiCo BioMed (KOSDAQ:214610) Using Debt In A Risky Way?

CEO

Young S Hong

1.3yrs

Tenure

Young S Hong is Chief Executive Officer of MiCo BioMed Co., Ltd. from 2023.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.